GE Healthcare and Veran have signed a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Verans ig4 navigation system in the U.S.

Eric Pauwels has joined radiosurgery developer Accuray as senior vice president (VP) and chief marketing officer, effective Jan. 17.

The AHRA and Toshiba have awarded grants to six U.S. healthcare facilities for education and patient care initiatives, with each receiving up to $7,500.

The use of intensity-modulated radiotherapy (IMRT) to treat head and neck cancer resulted in lower incidence of dry mouth, or xerostomia, thereby improving associated quality of life measures, a study published Jan. 13 in The Lancet concluded.

Stereotactic body radiotherapy (SBRT) may offer an effective and non-invasive treatment option for low-risk prostate cancer that is both shorter and results in lower toxicity than standard therapies, according to a study published Jan. 10 in Radiation Oncology.

In spite of falling cancer rates nearly across the board, the cost of cancer care in the U.S. is expected to spike by at least 27 percent by 2020, amounting to national expenditures between $155 and $207 billion, according to a study published Jan. 12 in the Journal of the National Cancer Institute.

The addition of docetaxel to an induction chemotherapy regiment in patients with locally advanced head and neck cancer improved five-year survival rates from 42 percent to 52 percent and nearly doubled median survival time, leading researchers to recommend the three-drug regiment for eligible patients, with the findings published Jan. 12 in The Lancet Oncology.

The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would establish a new hospital value-based purchasing program rewarding hospitals that perform well on quality measures relating both to clinical process of care and to patient experience of care, or those making improvements in their performance on those measures.